Skip to main content
. 2020 Nov 9;21(21):8407. doi: 10.3390/ijms21218407
BC bladder cancer
BCG bacillus Calmette–Guérin
BRIDGE Bladder Cancer Research Initiative for Drug Targets Germany
CSS cancer-specific survival
DFS
EAU
disease-free survival
European Association of Urology
HPF high power field
LA lymphocyte aggregates
MD medical doctor
MIBC muscle-invasive bladder cancer
NMIBC non-muscle-invasive bladder cancer
OS overall survival
PFS progression-free survival
RFS recurrence-free survival
ROI region of interest
TILs tumor-infiltrating lymphocytes
TLS tertiary lymphoid structures
TURB transurethral resection of the bladder
WHO World Health Organization